Cart summary

You have no items in your shopping cart.

Search results for: 'CD16'

Items 11 - 20 of 85

Show
per page
  • Greater than 95% as determined by reducing SDS-PAGE.

    Predicted: 21.9 KDa. Observed: 35-40 KDa, reducing conditions

    1 mg, 500 μg, 50 μg, 10 μg
  • Greater than 95% as determined by reducing SDS-PAGE.

    Predicted: 22 KDa. Observed: 35-40 KDa, reducing conditions

    1 mg, 500 μg, 50 μg, 10 μg
  • Greater than 95% as determined by reducing SDS-PAGE.

    Predicted: 21.9 KDa. Observed: 25-35 KDa, reducing conditions

    1 mg, 500 μg, 50 μg, 10 μg
  • ELISA,  MS,  SDS-PAGE,  WB

    Greater than 95% as determined by reducing SDS-PAGE.

    Human cells

    10 μg, 50 μg, 500 μg
  • ELISA,  MS,  SDS-PAGE,  WB

    Greater than 95% as determined by reducing SDS-PAGE.

    Human cells

    10 μg, 50 μg, 500 μg
  • ELISA,  MS,  SDS-PAGE,  WB

    Greater than 95% as determined by reducing SDS-PAGE.

    Human cells

    10 μg, 50 μg, 500 μg
  • ELISA,  MS,  SDS-PAGE,  WB

    Greater than 95% as determined by reducing SDS-PAGE.

    Human cells

    500 μg, 50 μg, 10 μg
  • Featured

    The purity of the protein is greater than 95% as determined by SDS-PAGE and Coomassie blue staining.

    The protein has a predicted molecular mass of 47.8 kDa after removal of the signal peptide. The apparent molecular mass of cFCGR3A-hFc is approximately 55-70 kDa due to glycosylation.

    10 μg, 50 μg, 100 μg
  • Greater than 95% as determined by SDS-PAGE.

    22.8 kDa

    Yeast

    20 μg, 100 μg, 1 mg
  • 32.64 kDa

    Human

    20 μg

Items 11 - 20 of 85

Show
per page